CAP Score of 337 is Likely Reversible with Weight Loss and Lifestyle Modification
A CAP (Controlled Attenuation Parameter) score of 337 dB/m indicates significant hepatic steatosis (grade 3), and this is potentially reversible through weight reduction and increased physical activity. This score reflects liver fat content measured by FibroScan, not male fertility parameters, and should be addressed through metabolic interventions.
Understanding Your CAP Score
Your CAP score of 337 dB/m falls into the severe steatosis range (typically >290-300 dB/m indicates grade 3 steatosis). This measurement quantifies fat accumulation in your liver and is commonly seen in metabolic dysfunction-associated steatotic liver disease (MASLD).
Evidence for Reversibility
The most compelling evidence shows that CAP scores can decrease substantially with lifestyle modifications 1. In a prospective study of NAFLD patients with elevated liver stiffness:
- Patients who lost ≥1 kg of weight reduced their CAP score by an average of 39 ± 63 dB/m compared to those who gained weight (24 ± 65 dB/m gain)
- Those who increased physical activity reduced CAP by 20 ± 71 dB/m compared to 32 ± 71 dB/m gain in inactive patients
- These changes occurred over 6-36 months of follow-up 1
One-third of patients with initially elevated liver stiffness showed reversal after just 4-6 months of intervention 1. This demonstrates that hepatic steatosis measured by CAP is a dynamic, modifiable condition.
Key Determinants of Your CAP Score
The primary drivers of elevated CAP scores are 2:
- Abdominal circumference (strongest predictor, p < 10⁻⁶)
- Fasting insulin levels (insulin resistance, p < 10⁻⁶)
- Body mass index (p < 10⁻⁴)
- Diabetes status
- Triglyceride levels
- HDL cholesterol (inversely related)
Specific Action Plan for Reversal
Weight Loss Target
- Aim for ≥5-10% body weight reduction
- Even modest weight loss of ≥1 kg has shown measurable CAP improvement
- Focus particularly on reducing abdominal circumference
Physical Activity
- Increase physical activity regardless of weight loss
- Independent beneficial effect on CAP scores demonstrated
- Both aerobic and resistance training recommended
Metabolic Optimization
- Address insulin resistance through dietary modification
- Control diabetes if present (HbA1c optimization)
- Manage dyslipidemia (lower triglycerides, raise HDL)
Monitoring Strategy
Repeat FibroScan in 6-12 months to assess response to interventions 1. A single elevated CAP measurement should not be considered permanent, as these values fluctuate significantly with lifestyle changes. Serial measurements provide the most accurate assessment of disease trajectory.
Important Caveats
- CAP scores correlate with liver stiffness measurements, so concurrent fibrosis assessment is important
- If liver stiffness measurement (LSM) is also elevated (≥8-10 kPa), more aggressive intervention and closer monitoring are warranted
- The relationship between CAP and clinical outcomes shows that in some contexts, the presence of steatosis may actually be associated with better outcomes in established liver disease 3, though this doesn't negate the importance of addressing metabolic dysfunction
Your CAP score of 337 represents reversible hepatic steatosis that should respond to weight loss and increased physical activity within 6-12 months of sustained lifestyle modification.